Repare Therapeutics Inc.
RPTX
$2.11
-$0.02-0.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 119.46% | 44.27% | -4.79% | 16.67% | 1.06% |
| Total Depreciation and Amortization | -93.05% | -12.65% | 161.23% | -5.02% | -2.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.06% | -186.17% | -14.20% | 2.91% | -16.42% |
| Change in Net Operating Assets | -60.49% | 165.78% | -13.46% | -230.53% | 30.78% |
| Cash from Operations | 116.22% | 43.91% | -6.62% | 10.53% | -0.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 362.29% | -102.04% | -8.85% | 1.63% | 336.64% |
| Cash from Investing | 532.94% | -102.04% | -8.85% | 1.63% | 336.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 7,800.00% | -99.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 7,800.00% | -99.40% | -- |
| Foreign Exchange rate Adjustments | -137.98% | -- | -- | -721.43% | 1,500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.77% | -6,311.83% | -106.27% | 479.20% | 103.08% |